microdosing glp 1 for rheumatoid arthritis GLP-1 Medications & Autoimmune Disease Honored to be featured in

While this regulatory oversight is designed to protect public health, it also means that patients and providers must navigate a more complex landscape to access these treatments

Monoclonal antibodies targeting A, such as aducanumab, lecanemab, and donanemab, have not demonstrated clinically meaningful efficacy (Terao and Kodama, 2024)

Instead, we got Ozempic face, celebrity gossip, and a cultural fixation on the cosmetic outcome, while ignoring the profound metabolic and health benefits that matter far more for healthspan

At oral doses in the range of 10 mcg/kg in drinking water, similar directional effects were observed in some colitis models, though effect sizes varied across experiments